BCL2 and neuroblastoma: Similar studies performed with human 293 kidney or SH-Sy5y neuroblastoma cells demonstrated significant reductions in bcl-2 (42% and 36.7%, resp.; P < .01), but no significant changes in the levels of FasR, FasL, or TNF-R1 expression (data not shown).